View in EDS PDF Full Text

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.

Saved in:
Bibliographic Details
Title: Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.
Authors: Rowaiye AB; National Biotechnology Development Agency, Abuja, Nigeria., Nwonu EJ; National Biotechnology Development Agency, Abuja, Nigeria., Asala TM; National Biotechnology Development Agency, Abuja, Nigeria., Ogu AC; National Biotechnology Development Agency, Abuja, Nigeria., Bur D; National Biotechnology Development Agency, Abuja, Nigeria., Chukwu C; National Biotechnology Development Agency, Abuja, Nigeria., Oli AN; Department of Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria., Agbalalah T; National Biotechnology Development Agency, Abuja, Nigeria.; Department of Anatomy, Baze University, Abuja, Nigeria.
Source: Clinical and experimental vaccine research [Clin Exp Vaccine Res] 2022 Sep; Vol. 11 (3), pp. 249-263. Date of Electronic Publication: 2022 Sep 30.
Publication Type: Journal Article
Journal Info: Publisher: Korean Vaccine Society Country of Publication: Korea (South) NLM ID: 101592344 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-3651 (Print) Linking ISSN: 22873651 NLM ISO Abbreviation: Clin Exp Vaccine Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36451670
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rowaiye+AB%22">Rowaiye AB</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Nwonu+EJ%22">Nwonu EJ</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Asala+TM%22">Asala TM</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Ogu+AC%22">Ogu AC</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Bur+D%22">Bur D</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Chukwu+C%22">Chukwu C</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Oli+AN%22">Oli AN</searchLink>; Department of Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.<br /><searchLink fieldCode="AU" term="%22Agbalalah+T%22">Agbalalah T</searchLink>; National Biotechnology Development Agency, Abuja, Nigeria.; Department of Anatomy, Baze University, Abuja, Nigeria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101592344%22">Clinical and experimental vaccine research</searchLink> [Clin Exp Vaccine Res] 2022 Sep; Vol. 11 (3), pp. 249-263. <i>Date of Electronic Publication: </i>2022 Sep 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Vaccine+Society%22">Korean Vaccine Society </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101592344 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2287-3651 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222873651%22">22873651 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Vaccine Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36451670
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7774/cevr.2022.11.3.249
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 249
    Titles:
      – TitleFull: Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rowaiye AB
      – PersonEntity:
          Name:
            NameFull: Nwonu EJ
      – PersonEntity:
          Name:
            NameFull: Asala TM
      – PersonEntity:
          Name:
            NameFull: Ogu AC
      – PersonEntity:
          Name:
            NameFull: Bur D
      – PersonEntity:
          Name:
            NameFull: Chukwu C
      – PersonEntity:
          Name:
            NameFull: Oli AN
      – PersonEntity:
          Name:
            NameFull: Agbalalah T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2287-3651
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical and experimental vaccine research
              Type: main
ResultId 1